SARS-CoV-2
SARS-CoV-2 Overview
The novel coronavirus SARS-CoV-2 causing the COVID-19 pandemic has emerged quickly and is in the centre of global life science research.
SARS-CoV-2 Portfolio
We are happy to cooperate with our highly experienced partners Cellecta, Mawi DNA Technologies, Paragon Genomics and YouSeq to offer their complete portfolio, including sample collection devices, qRT-PCR kits, NGS amplicon panels, lentiviral constructs for host and virus entry factor expression, pseudotyped lentiviral particles, and services.
SARS-CoV-2 NGS Panel
The newest additions to the portfolio are the CleanPlex SARS-CoV-2 FLEX NGS Panel which was developed by Paragon Genomics for sequencing of emerging virus mutations and Cellecta´s S-protein pseudotyped lentiviral particles featuring wild type spike-protein as well as all variants of concern.
-
SARS-CoV-2 Sample Collection (4)
-
SARS-CoV-2 qPCR Assays (17)
-
SARS-CoV-2 NGS Library Prep Kit (1)
-
SARS-CoV-2 and Influenza/RSV NGS Amplicon Panels (12)
-
SARS-CoV-2 Host Cell Entry Factor Sequencing (2)
-
SARS-CoV-2 Host Cell Entry Factor Expression Constructs (8)
-
SARS-CoV-2 Host Cell Entry Factor Expression Cell Lines (4)
-
SARS-CoV-2 Virus Entry Factor Expression Constructs (2)
-
SARS-CoV-2 Spike-Protein Pseudotyped Lentiviral Particles (60)
-
SARS-CoV-2 Spike-Protein Pseudotyped Lentiviral Production (9)
-
SARS-CoV-2 Services (2)